{"id":250752,"date":"2022-09-28T00:00:00","date_gmt":"2022-09-28T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/products\/research-reports\/report\/epidim0036-biopharma-focal-segmental-glomerulosclerosis-epidemiology\/"},"modified":"2026-05-11T23:29:12","modified_gmt":"2026-05-11T23:29:12","slug":"epidim0036-biopharma-focal-segmental-glomerulosclerosis-epidemiology-mature-markets","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/epidim0036-biopharma-focal-segmental-glomerulosclerosis-epidemiology-mature-markets\/","title":{"rendered":"Focal Segmental Glomerulosclerosis &#8211; Epidemiology &#8211; Mature Markets"},"content":{"rendered":"<p>Clarivate Epidemiology\u2019s coverage of focal segmental glomerulosclerosis (<abbr title=\"focal segmental\u00a0glomerulosclerosis\">FSGS<\/abbr>) comprises epidemiological estimates of key patient populations in the major mature pharmaceutical markets (the United States, France, Germany, Italy, Spain, the United Kingdom, and Japan). We report both the incidence and prevalence of <abbr title=\"focal segmental\u00a0glomerulosclerosis\">FSGS<\/abbr> for each country, as well as annualized case counts projected to the national population.<\/p>\n<p>The patient populations are forecast over a period of 20 years for the major mature pharmaceutical markets.<\/p>\n<p>Clarivate Epidemiology\u2019s <abbr title=\"focal segmental\u00a0glomerulosclerosis\">FSGS<\/abbr> forecast will answer the following question:<\/p>\n<ul class=\"round-bullets\">\n<li>How will demographic trends, such as population aging and improving life expectancy, affect the epidemiology of <abbr title=\"focal segmental\u00a0glomerulosclerosis\">FSGS<\/abbr> over the forecast period?<\/li>\n<\/ul>\n<p>All forecast data are available on the Clarivate Insights Platform in tabular format, with options to download to <span class=\"abbreviation-guard\">MS <\/span>Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is also provided for full transparency into research and methods.<\/p>\n<p>Clarivate Epidemiology forecasts the following <abbr title=\"focal segmental\u00a0glomerulosclerosis\">FSGS<\/abbr> patient populations:<\/p>\n<ul class=\"round-bullets\">\n<li>Diagnosed incident cases of <abbr title=\"focal segmental\u00a0glomerulosclerosis\">FSGS<\/abbr>.<\/li>\n<li>Diagnosed prevalent cases of <abbr title=\"focal segmental\u00a0glomerulosclerosis\">FSGS<\/abbr>.<\/li>\n<li>Diagnosed incident cases of end-stage <abbr title=\"focal segmental\u00a0glomerulosclerosis\">FSGS<\/abbr>.<\/li>\n<li>Diagnosed prevalent cases of end-stage <abbr title=\"focal segmental\u00a0glomerulosclerosis\">FSGS<\/abbr>.<\/li>\n<\/ul>\n<p>Note: Coverage may vary by country.<\/p>\n<ul class=\"round-bullets\">\n<\/ul>\n","protected":false},"template":"","class_list":["post-250752","report","type-report","status-publish","hentry","report-gateway-biopharma","biopharma-therapy-areas-focal-segmental-glomerulosclerosis","biopharma-product-epidemiology","biopharma-date-960"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/250752","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":2,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/250752\/revisions"}],"predecessor-version":[{"id":396620,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/250752\/revisions\/396620"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=250752"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}